HealthcareGoldman Sachs upgrades Amgen (NASDAQ:AMGN) to Neutral from Sell on the heels of the biotech...Dec. 16, 2011 7:07 AM ETAmgen Inc. (AMGN) StockAMGNBy: Clark Schultz, SA News EditorGoldman Sachs upgrades Amgen (NASDAQ:AMGN) to Neutral from Sell on the heels of the biotech concern's change in management. Analysts with the firm have been calling for a "new strategic direction" for AMGN for quite a while. Recommended For YouMore Trending NewsSee More »About AMGN StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgAMGN--Amgen Inc.Trending AnalysisTrending News